Investigating the Role of Gut Microbiota-Derived Metabolites on Autonomic Regulation of Cardiovascular Function in Hypertensive Rat Models

Project Abstract

This study investigates the mechanistic links between gut microbiota-derived metabolites and autonomic control of cardiovascular function in hypertensive rat models, aiming to identify metabolite signatures that contribute to sympathetic overactivity, baroreflex impairment, and vascular dysfunction. Hypertension is modeled in rats using established dietary and pharmacological inducers to emulate chronic elevated blood pressure and end-organ risk. We hypothesize that microbial metabolites, including short-chain fatty acids, trimethylamine-N-oxide, secondary bile acids, and tryptophan-derived indoles, modulate autonomic balance through afferent neural pathways, central autonomic networks, and peripheral vascular reactivity. A multi-omics approach combines metagenomics to profile gut microbial composition, metabolomics to quantify circulating and tissue-specific metabolites, and transcriptomics to assess gene expression changes in autonomic centers such as the brainstem and hypothalamic nuclei. Hemodynamic assessments include telemetric blood pressure monitoring, heart rate variability analysis, and baroreflex sensitivity testing, complemented by pharmacologic provocations targeting adrenergic and parasympathetic signaling. We integrate these data with vascular reactivity assays and endothelial function markers to delineate how microbial metabolites influence vascular tone and resistance. A primary aim is to determine whether specific metabolites correlate with alterations in sympathetic predominance, diminished baroreflex gain, or impaired vagal-heart coupling, and whether microbiota-derived signals modulate renal sympathetic activity that sustains hypertension. Secondary aims examine causal relationships using antibiotic-mediated microbiota depletion and fecal microbiota transplantation to transfer hypertensive phenotypes, evaluating subsequent shifts in autonomic metrics and metabolite profiles. The study also probes gut barrier integrity and systemic inflammation as mediators linking dysbiosis to autonomic dysregulation, assessing circulating cytokines, endotoxin levels, and tight junction protein expression. Advanced statistical modeling and machine learning strategies will integrate high-dimensional datasets to construct predictive networks of microbe-metabolite-autonomic interactions and identify potential biomarkers or therapeutic targets. Expected outcomes include a delineation of metabolite signatures that discriminate hypertensive from normotensive phenotypes, mechanistic insights into how microbial signals influence central autonomic nuclei and peripheral vascular reactivity, and proof-of-concept data supporting microbiota-targeted interventions to restore autonomic balance and ameliorate hypertension. The translational relevance lies in informing precision medicine strategies that leverage gut microbiota modulation—via diet, prebiotics, probiotics, or targeted metabolites—to tune autonomic control and reduce cardiovascular risk in hypertension. Findings will contribute to a framework integrating microbiology, neuroscience, and cardiovascular physiology, highlighting gut-heart-brain axis dynamics as pivotal determinants of hypertensive pathology and potential disease-modifying therapies.

Project Overview

What This Project Is About

---

A straightforward, beginner-friendly look at how bacteria in the gut create chemicals that might influence the nerves controlling the heart and blood vessels, especially in high blood pressure. The project explores whether gut-made signals can affect heart rate, blood pressure, and blood vessel function in rats with hypertension.

---

---

The Problem It Addresses

---

We know gut bacteria produce chemicals that can alter body systems, but it isn’t clear how these signals relate to the brain’s control of the heart and vessels in high blood pressure. This gap makes it hard to design new, safe treatments that target the gut to help heart health.

---

---

Objectives of the Project

---

1. Identify specific gut-derived metabolites linked to autonomic (nerve-based) regulation of cardiovascular function.
2. Monitor changes in heart rate, blood pressure, and vessel health in hypertensive rats after altering gut signals.
3. Assess whether blocking or boosting certain gut signals changes autonomic responses.
4. Illustrate potential pathways that connect the gut to the brain and heart in hypertension.
5. Provide foundational data for future, targeted therapies aiming at the gut–brain–heart axis.

---

---

What You Will Do Step by Step

---

1. Review basic literature on gut microbiota and cardiovascular control.
2. Induce hypertension in rats using standard, humane methods.
3. Collect blood pressure, heart rate, and nerve activity data under different gut metabolite conditions.
4. Analyze gut metabolites from fecal samples and relate them to cardiovascular measurements.
5. Test interventions that modify gut signals (e.g., antibiotics or metabolite supplements) and observe effects.
6. Summarize findings and discuss possible mechanisms and limitations.

---

---

Expected Outcome

The project is expected to show a link between certain gut metabolites and autonomic control of cardiovascular function in hypertensive rats, highlighting potential targets for gut-based therapies and guiding future studies in humans.